Suregraft 0.5 MG Tablet 10 is used primarily to prevent organ rejection in patients who have undergone transplantation procedures. It belongs to a class of medications known as immunosuppressants.
In addition to its primary use, this medicine is also effective in managing various types of cancer, including advanced kidney cancer, hormone receptor-positive breast cancer, pancreatic neuroendocrine tumours, non-small cell lung cancer, and subependymal giant cell astrocytoma associated with tuberous sclerosis.
This medicine should be taken as directed by your doctor, who will determine the appropriate dosage based on your specific condition and response to treatment. Before starting this medicine, inform your doctor about any pre-existing medical conditions or ongoing medications. If you notice any unusual side effects while taking this medicine, notify your doctor immediately. Continue taking the medicine for the entire duration prescribed by your doctor for optimal results.



































